Bulters, Mr Diederik

Diederik BultersSpecialty

Neurosurgery

Sub-specialty

Vascular neurosurgery

Training and education

  • MBChB and intercalated BSc in pharmacology, concentrating on neurophysiology, University of Edinburgh.
  • Basic surgical training, University of Edinburgh.
  • Specialist neurosurgical training, Wessex.
  • Fellowship in neurovascular surgery, Cambridge.

Experience

Mr Bulters is a consultant neurosurgeon with a specialist interest in vascular neurosurgery and head injury. After completing his fellowship in Cambridge he stayed on as a consultant neurosurgeon, before moving back to Southampton.

Key achievements

  • Member of the Society of British Neurological Surgeons, British Neurovascular group, European Association of Neurosurgical Societies and the Congress of Neurological Surgeons. 
  • Regularly teaches and lectures on a wide range of courses including the British Neurosurgical Trainees Association, UK Neurovascular Group, and Cambridge Lectures in Neurosurgical Anatomy. 
  • Member of the Society of British Neurological Surgeons Research Committee and a reviewer for a range of neurosurgical journals and associate editor of the British Journal of Neurosurgery.

Research

Mr Bulters has an active research interest in the fields of vascular neurosurgery and head injury. He holds grants from the NIHR, EPSRC, TSB, MRC, European Union, Royal College of Surgeons of Edinburgh and Wessex Medical Research. 

Mr Butlers is currently the chief and principal investigator for a large portfolio of randomised trials examining new ways to improve outcomes following intracranial haemorrhage and head injury, utilising new drug interventions and surgical techniques.

He is also an honorary clinical lecturer at the University of Southampton, specialising in the translation of laboratory studies into clinical intervention. At the university he works closely with the team to investigate the biochemical effects of haemorrhage and head injury on the brain, and how these may be manipulated and ameliorated. This has led to a number of exciting putative interventions that are proceeding into human clinical trials.